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In this issue… (doi:10.1016/j.scr.2008.11.001)Jason Kovacic and Manfred Boehm discuss progenitor
cells within the vasculature in their review entitled Resident
vascular progenitor cells: An emerging role for non-
terminally differentiated vessel-resident cells in vascular
biology. The vasculature plays an important role in a range of
biologic processes, such as the provisioning of hematopoietic
stem cells during embryonic development and the regulation
of vascular tone and blood pressure. This review explores the
various stem and progenitor cell populations that are
resident in the microvasculature, endothelium, and vessel
walls.
A second review, The therapeutic potential of bone
marrow-derived mesenchymal stem cells on hepatic
cirrhosis, by Long-Jun Dai and colleagues, discusses the
potential beneficial effects that mesenchymal stem cells
may have in cirrhosis, including hepatocyte-like differentia-
tion and attenuation of hepatic fibrosis.
In their commentary Stem Cells and the Price of
Immortality, Andrew Holland and Ed Stanley, begin with
the statement that “Creating b cells for the treatment of
diabetes has been one of the most avidly pursued goals in the
field of stem cell differentiation”. They discuss two reports
from the laboratory of Sai Kang Lim describing the genera-
tion of immortalised insulin-producing cell lines from a
population of lineage-restricted stem cells, starting either
with the mouse embryo (GuoDong Li and colleagues,
Derivation of functional insulin-producing cell lines from
primary mouse embryo culture) or with mouse embryonic
stem cells (GuoDong Li and colleagues, Generating mESC-
derived insulin-producing cell lines through an intermedi-
ate lineage-restricted progenitor line). Whilst clonal
insulin-producing cell lines were generated that were able
to reduce blood glucose in diabetic mice, it was concerning
that the lines displayed some features of transformation
including an unstable karyotype.
Elisabet Akesson and colleagues examine the immunolo-
gical responses to transplanted neural stem cells in their1873-5061/$ – see front matter © 2008 Published by Elsevier B.V.
doi:10.1016/j.scr.2008.11.001paper, Human neural stem cells and astrocytes, but not
neurons, suppress an allogeneic lymphocyte response.
Their findings indicate that donor NSCs and astrocytes, but
not the neurons, exhibited a suppressive effect on an
allogeneic immune response, but they could not block graft
rejection in a xenogeneic setting.
Weigang Gu and colleagues report experiments that
investigate neurogenesis in the cerebral cortex of rats
after ischemic stroke. Their study, titled Cell division in
the cerebral cortex of adult rats after photothrombotic
ring stroke, suggests that in response to a sublethal ischemic
insult, endogenous cells with neuronal immunolabeling may
duplicate their nuclear DNA and commit cell mitosis to
generate daughter neurons.
In a study that examines the generation of Human ESC
lines from blastocysts with proven meiotic or mitotic errors,
Yury Verlinsky and colleagues describe the Correlation
between preimplantation genetic diagnosis for chromoso-
mal aneuploidies and the efficiency of establishing human
ES cell lines. An interesting conclusion from their study is
that it may prove very difficult to obtain abnormal hESC lines
for scientific study from aneuploid PGD embryos, limiting our
ability to study the biological consequences of chromosomal
abnormalities.
Finally, in their study titled Enumeration of the colony-
forming units–fibroblast from mouse and human bone
marrow in normal and pathological conditions, Sergei
Kuznetsov and colleagues compared the concentrations of
stromal clonogenic cells in a number of normal samples,
generated from several inbred mouse strains and normal
human donors, and pathological samples of murine and
human origin. They showed that colony forming efficiency
was significantly altered in patients with a range of skeletal,
metabolic and haematological disorders.
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